US FDA Elevates Controlled Substances Coordinator To New Deputy CDER Director Role
The move should increase the visibility of the FDA’s wide-ranging, and widely criticized, opioid epidemic response.

The move should increase the visibility of the FDA’s wide-ranging, and widely criticized, opioid epidemic response.